Works matching DE "CANCER relapse"


Results: 5000
    1
    2
    3

    Prognostic Nutrition Index as a Biomarker for Treatment Sensitivity to Chemotherapy and Nivolumab as the First-Line Treatment in Patients with Unresectable Advanced or Recurrent Gastric Cancer: A Multicenter Study.

    Published in:
    Oncology, 2025, v. 103, n. 6, p. 469, doi. 10.1159/000541544
    By:
    • Nakazawa, Nobuhiro;
    • Sano, Akihiko;
    • Kumakura, Yuji;
    • Yamashita, Toshiki;
    • Tanaka, Naritaka;
    • Saito, Kana;
    • Kimura, Akiharu;
    • Kasuga, Kengo;
    • Nakazato, Kenji;
    • Yoshinari, Daisuke;
    • Shimizu, Hisashi;
    • Ubukata, Yasunari;
    • Hosaka, Hisashi;
    • Shiraishi, Takuya;
    • Sakai, Makoto;
    • Sohda, Makoto;
    • Shirabe, Ken;
    • Saeki, Hiroshi
    Publication type:
    Article
    4
    5
    7
    8
    9

    Differential susceptibility and role for senescence in CART cells based on costimulatory domains.

    Published in:
    Molecular Cancer, 2025, v. 24, n. 1, p. 1, doi. 10.1186/s12943-025-02371-1
    By:
    • Can, Ismail;
    • Siegler, Elizabeth L.;
    • Sirpilla, Olivia L.;
    • Manriquez-Roman, Claudia;
    • Yun, Kun;
    • Stewart, Carli M.;
    • Feigin, Jennifer M.;
    • Rodriguez, Makena L.;
    • Gutierrez-Ruiz, Omar L.;
    • Ogbodo, Ekene J.;
    • Huynh, Truc N.;
    • Kimball, Brooke L.;
    • Mai, Long K.;
    • Hefazi, Mehrdad;
    • Fonkoua, Lionel Kankeu;
    • Xia, Hong;
    • Hamaidi, Imene;
    • Alkan, Berke;
    • Sezer, Fatih;
    • Ekiz, H. Atakan
    Publication type:
    Article
    10
    11
    12
    13
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33

    复发/转移性鼻咽癌治疗进展.

    Published in:
    Chinese Journal of Oncology Prevention & Treatment, 2025, v. 17, n. 2, p. 215, doi. 10.3969/j.issn.1674⁃5671.2025.02.13
    By:
    • 钟丽梅;
    • 金风
    Publication type:
    Article
    34
    35
    36

    PARP inhibitors as maintenance therapy in ovarian cancer after platinum-sensitive recurrence: real-world experience from the Unicancer network.

    Published in:
    Oncologist, 2025, v. 30, n. 5, p. 1, doi. 10.1093/oncolo/oyaf075
    By:
    • Rippstein, Nicolas;
    • Zemmour, Christophe;
    • Rodrigues, Manuel;
    • Ray-Coquard, Isabelle;
    • Gladieff, Laurence;
    • Pautier, Patricia;
    • Frénel, Jean-Sébastien;
    • Costaz, Hélène;
    • Lebreton, Coriolan;
    • Pomel, Christophe;
    • Colombo, Pierre-Emmanuel;
    • Marchal, Frédéric;
    • Guillemet, Cécile;
    • Rouge, Thibault de la Motte;
    • Eberst, Lauriane;
    • Bosquet, Lise;
    • Deluche, Elise;
    • Sabatier, Renaud
    Publication type:
    Article
    37

    On the Horizon: A Global Multidisciplinary Perspective on Delivering Emerging Therapies for Patients with BCG-Naïve High-Risk NMIBC.

    Published in:
    Oncology & Therapy, 2025, v. 13, n. 2, p. 275, doi. 10.1007/s40487-025-00334-6
    By:
    • Szabados, Bernadett E.;
    • Guerrero-Ramos, Félix;
    • Grande, Enrique;
    • Grivas, Petros;
    • Grünwald, Viktor;
    • Miguel, Marta Carpintero;
    • Hussain, Syed A.;
    • Kulkarni, Girish S.;
    • Wilson, Ana Lisa;
    • Shore, Neal D.;
    • Sridhar, Srikala S.;
    • Hoyt, Mary;
    • Strumeier, Samantha;
    • Sutton, Jennifer;
    • Brinkmann, Julia;
    • Teresi, Rosemary E.;
    • Todenhöfer, Tilman
    Publication type:
    Article
    38

    Cost-Effectiveness of Elranatamab Versus Current Therapies for the Management of Patients with Triple-Class Exposed, Relapsed and Refractory Multiple Myeloma, Including Other Bispecific and Physician's Choice of Treatment in Spain.

    Published in:
    Oncology & Therapy, 2025, v. 13, n. 2, p. 381, doi. 10.1007/s40487-025-00333-7
    By:
    • Encinas, Cristina;
    • Lozano, Virginia;
    • Hlavacek, Patrick;
    • Llinares, Julia;
    • Toribio-Castelló, Sofía;
    • Carcedo, David;
    • Asís-Montalt, Jordi;
    • Martínez-López, Joaquín
    Publication type:
    Article
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50